Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract 347: Tumor necrosis factor related apoptosis inducing ligand (TRAIL)-induced cytokine production in TNBC promotes neutrophil chemotaxis and immune suppression

Manjari Kundu, Yoshimi Endo Greer, Lisa Ann Ridnour, David A Wink, Yeap S. Ng, Roberto Weigert, Stan Lipkowitz

Cancer Res (2024) 84 (6_Supplement): 347.

https://doi.org/10.1158/1538-7445.AM2024-347

Published: 22 March 2024

View article titled, Abstract 347: Tumor necrosis factor related apoptosis inducing ligand (TRAIL)-induced cytokine production in TNBC promotes neutrophil chemotaxis and immune suppression

Journal Articles

Abstract 2539: Tumor necrosis factor related apoptosis inducing ligand (TRAIL) induces cytokine release via the alternative NFKB2 pathway in triple negative breast cancer cells (TNBC) and modulates neutrophil chemotaxis

Manjari Kundu, Yoshimi Endo Greer, Lisa A. Ridnour, David A. Wink, Stan Lipkowitz

Cancer Res (2023) 83 (7_Supplement): 2539.

https://doi.org/10.1158/1538-7445.AM2023-2539

Published: 04 April 2023

View article titled, Abstract 2539: Tumor necrosis factor related apoptosis inducing ligand (TRAIL) induces cytokine release via the alternative NFKB2 pathway in triple negative breast cancer cells (TNBC) and modulates neutrophil chemotaxis

Journal Articles

Abstract OT1-08-01: A phase Ib trial of sequential combinations of BN-brachyury, entinostat, ado-trastuzumab emtansine (T-DM1) and bintrafusp alfa (M7824) in advanced stage breast cancer (BrEAsT)

Margaret E Gatti-Mays, Claudia Palena, Sofia R Gameiro, Renee N Donahue, Caroline Jochems, Seth Steinberg, Stan Lipkowitz, Alexandra Zimmer, Deneise Francis, Julius Strauss, Houssein Abdul Sater, Lisa Cordes, Jason Redman, Fatima Karzai, Marijo Bilusic, Ravi A Madan, James L Gulley, Jeffrey Schlom

Cancer Res (2020) 80 (4_Supplement): OT1-08-01.

https://doi.org/10.1158/1538-7445.SABCS19-OT1-08-01

Published: 15 February 2020

View article titled, Abstract OT1-08-01: A phase Ib trial of sequential combinations of BN-brachyury, entinostat, ado-trastuzumab emtansine (T-DM1) and bintrafusp alfa (M7824) in advanced stage breast cancer (BrEAsT)

Journal Articles

Abstract CT058: A phase 2 open-label study to evaluate the efficacy and safety of VT-464 in patients with androgen receptor positive triple-negative breast cancer patients, and men with ER positive breast cancer

Alexandra Zimmer, Margaret E. Gatti-Mays, Stan Lipkowitz, Fatima Karzai, James Gulley, William Dahut, Seth Steinberg, William D. Figg, Ravi Madan

Cancer Res (2017) 77 (13_Supplement): CT058.

https://doi.org/10.1158/1538-7445.AM2017-CT058

Published: 01 July 2017

View article titled, Abstract CT058: A phase 2 open-label study to evaluate the efficacy and safety of VT-464 in patients with androgen receptor positive triple-negative breast cancer patients, and men with ER positive breast cancer

Journal Articles

Abstract #2842: Identification of Wee1 as a molecular target in basal-type breast cancer by an siRNA screen of the human kinome

Sireesha Garimella, Lyndsay Murrow, Natasha Caplen, Stan Lipkowitz

Cancer Res (2009) 69 (9_Supplement): 2842.

Published: 01 May 2009

View article titled, Abstract #2842: Identification of Wee1 as a molecular target in basal-type breast cancer by an siRNA screen of the human kinome

Journal Articles

Inhibition of epidermal growth factor receptor (EGFR) signaling enhances TRAIL-induced apoptosis in breast cancer cells by a PI3-kinase dependant but Akt independent mechanism

Monzur Rahman, Jing Bao, Marion M. Nau, Dao M. Nguyen, Stan Lipkowitz

Cancer Res (2006) 66 (8_Supplement): 176–177.

Published: 15 April 2006

View article titled, Inhibition of epidermal growth factor receptor (EGFR) signaling enhances TRAIL-induced apoptosis in breast cancer cells by a PI3-kinase dependant but Akt independent mechanism

Journal Articles

The constitutively active EGFR vIII and hyperactive L858R EGFR mutants do not escape Cbl mediated ubiquitination and degradation

Gareth C. Davies, Phillip E. Ryan, Lambratu Rahman, Maria Zajac-Kaye, Stan Lipkowitz

Cancer Res (2005) 65 (9_Supplement): 1018.

Published: 01 May 2005

View article titled, The constitutively active EGFR vIII and hyperactive L858R EGFR mutants do not escape Cbl mediated ubiquitination and degradation

Journal Articles

Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b

Gareth C. Davies, Seth A. Ettenberg, Ashley O. Coats, Mark Mussante, Sarangan Ravichandran, Jack Collins, Marion M. Nau, Stan Lipkowitz

Cancer Res (2004) 64 (7_Supplement): 907.

Published: 01 April 2004

View article titled, Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b

Journal Articles

RING finger-mediated instability of Cbl-c

Ashley O. Coats, Yaffa R. Rubinstein, Nina Sivadasan, Mauricio Cuello, Marion M. Nau, Stan Lipkowitz

Cancer Res (2004) 64 (7_Supplement): 201.

Published: 01 April 2004

View article titled, RING finger-mediated instability of Cbl-c

Journal Articles

Resveratrol enhances TRAIL-mediated apoptosis in breast and ovarian cancer cells.

Monzur Rahman, Isaac Darko, Mauricio Cuello, Stan Lipkowitz

Cancer Res (2004) 64 (7_Supplement): 826.

Published: 01 April 2004

View article titled, Resveratrol enhances TRAIL-mediated apoptosis in breast and ovarian cancer cells.

Journal Articles

Inhibition of epidermal growth factor receptor (EGFR) signaling enhances TRAIL-induced apoptosis in breast cancer cells.

Jing Bao, Monzur Rahman, Stan Lipkowitz

Cancer Res (2004) 64 (7_Supplement): 825.

Published: 01 April 2004

View article titled, Inhibition of epidermal growth factor receptor (EGFR) signaling enhances TRAIL-induced apoptosis in breast cancer cells.

Journal Articles

Down-Regulation of the erbB-2 Receptor by Trastuzumab (Herceptin) Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Breast and Ovarian Cancer Cell Lines that Overexpress erbB-2

Mauricio Cuello, Seth A. Ettenberg, Amy S. Clark, Maccon M. Keane, Reuben H. Posner, Marion M. Nau, Phillip A. Dennis, Stan Lipkowitz

Cancer Res (2001) 61 (12): 4892–4900.

Published: 01 June 2001

View article titled, Down-Regulation of the erbB-2 Receptor by Trastuzumab (Herceptin) Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Breast and Ovarian Cancer Cell Lines that Overexpress erbB-2

Journal Articles

Chemotherapy Augments TRAIL-induced Apoptosis in Breast Cell Lines

Maccon M. Keane, Seth A. Ettenberg, Marion M. Nau, Edward K. Russell, Stan Lipkowitz

Cancer Res (1999) 59 (3): 734–741.

Published: 01 February 1999

View article titled, Chemotherapy Augments TRAIL-induced Apoptosis in Breast Cell Lines

Journal Articles

Fas Expression and Function in Normal and Malignant Breast Cell Lines

Maccon M. Keane, Seth A. Ettenberg, Geoffrey A. Lowrey, Edward K. Russell, Stan Lipkowitz

Cancer Res (1996) 56 (20): 4791–4798.

Published: 01 October 1996

View article titled, Fas Expression and Function in Normal and Malignant Breast Cell Lines

Journal Articles

The Protein Tyrosine Phosphatase DEP-1 Is Induced during Differentiation and Inhibits Growth of Breast Cancer Cells

Maccon M. Keane, Geoffrey A. Lowrey, Seth A. Ettenberg, Mark A. Dayton, Stan Lipkowitz

Cancer Res (1996) 56 (18): 4236–4243.

Published: 01 September 1996

View article titled, The Protein Tyrosine Phosphatase DEP-1 Is Induced during Differentiation and Inhibits Growth of Breast Cancer Cells

NARROW

Abstract 347: Tumor necrosis factor related apoptosis inducing ligand (TRAIL)-induced cytokine production in TNBC promotes neutrophil chemotaxis and immune suppression

Abstract 2539: Tumor necrosis factor related apoptosis inducing ligand (TRAIL) induces cytokine release via the alternative NFKB2 pathway in triple negative breast cancer cells (TNBC) and modulates neutrophil chemotaxis

Abstract OT1-08-01: A phase Ib trial of sequential combinations of BN-brachyury, entinostat, ado-trastuzumab emtansine (T-DM1) and bintrafusp alfa (M7824) in advanced stage breast cancer (BrEAsT)

Abstract CT058: A phase 2 open-label study to evaluate the efficacy and safety of VT-464 in patients with androgen receptor positive triple-negative breast cancer patients, and men with ER positive breast cancer

Abstract #2842: Identification of Wee1 as a molecular target in basal-type breast cancer by an siRNA screen of the human kinome

Inhibition of epidermal growth factor receptor (EGFR) signaling enhances TRAIL-induced apoptosis in breast cancer cells by a PI3-kinase dependant but Akt independent mechanism

The constitutively active EGFR vIII and hyperactive L858R EGFR mutants do not escape Cbl mediated ubiquitination and degradation

Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b

RING finger-mediated instability of Cbl-c

Resveratrol enhances TRAIL-mediated apoptosis in breast and ovarian cancer cells.

Inhibition of epidermal growth factor receptor (EGFR) signaling enhances TRAIL-induced apoptosis in breast cancer cells.

Down-Regulation of the erbB-2 Receptor by Trastuzumab (Herceptin) Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Breast and Ovarian Cancer Cell Lines that Overexpress erbB-2

Chemotherapy Augments TRAIL-induced Apoptosis in Breast Cell Lines

Fas Expression and Function in Normal and Malignant Breast Cell Lines

The Protein Tyrosine Phosphatase DEP-1 Is Induced during Differentiation and Inhibits Growth of Breast Cancer Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only